cytokin influenc kill fresh chronic lymphocyt leukemia cell human leukocyt feasibl monoclon antibodi moab interferon-gamma ifn-gamma treatment chronic lymphocyt leukemia cll vitro tumor lysi model fresh cll cell differ patient target distinct normal human leukocyt effector subset neutrophil peripher blood mononuclear cell pbmc antigen express express cll-associ antigen cll cell neutrophil ifn-gamma absenc neutrophil cytotox adcc absenc ifn-gamma weak inconsist ifn-gamma exposur moab-depend lysi cll target eightfold augment neutrophil adcc remaind cytotox express confirm need interact neutrophil igg Fc receptor Fc gamma Rs Fc portion moab purifi staphylococcu aureu protein spa adcc ifn-gamma exposur consist altern express cll cell target antigen upregul unlik augment neutrophil adcc pbmc ifn-gamma presenc absenc ifn-gamma unabl cll target pbmc abl raji burkitt lymphoma cell conjunct abil target lytic function intact result import fresh tumor cell differ leukocyt effector subset clinic trial therapeut moab cytokin 